Peptide and Oligonucleotide CDMO Market

The Peptide and Oligonucleotide CDMO market provides specialized contract development and manufacturing services for complex biomolecules. Key customers include biopharmaceutical companies, pharmaceutical firms, and research institutes who outsource synthesis to leverage expertise, reduce costs, and ensure regulatory compliance. Market growth is primarily driven by the rising demand for personalized medicine, increased R&D activities in biopharma, and significant therapeutic and diagnostic advancements.